What do pharmacists need to know about nitazenes?

PSA #AustralianPharmacist Suzanne Nielsen PhD MPS

australianpharmacist.com.au/what-do-pharma…

Full house at the Monash Addiction Research Centre Emerging Researcher Symposium listening to Amanda Roxburgh present on coroner's data around Novel Synthetic Opioids

Great to see awareness increasing about #naloxone .. new research at the Monash Addiction Research Centre symposium today highlighted
in the Guardian Australia today Louisa Picco amp.theguardian.com/australia-news…

🚨New paper out today🚨Stocking and supplying naloxone: Findings from a representative sample of community pharmacies in Victoria, Australia - led by Louisa Picco at Monash Addiction Research Centre onlinelibrary.wiley.com/doi/10.1111/da…

'Medically supervised safe injection rooms save lives.
The decision to not open a second MSIR in the Melbourne CBD, goes against an abundance of compelling evidence, and expert advice - Sheree Lowe Executive Director Balit Durn Durn Centre

vaccho.org.au/2024/04/24/not…

Supervised injetable treatment is so hard to scale. We modelled different options and came to the same conclusion about unsupervised dosing pubmed.ncbi.nlm.nih.gov/36182753/

Nitazenes can be up to 50 times stronger than fentanyl.

Suzanne Nielsen PhD MPS + colleagues (@MonashUni, Burnet Institute) write that they’re not yet common in Australia, so now is the time to implement policies to reduce their harm. theconversation.com/opioids-more-p…

Opioids more potent than #fentanyl have been detected in Australia. So what are #nitazenes ? Monash Addiction Research Centre theconversation.com/opioids-more-p… via The Conversation - Australia + New Zealand

Really looking forward to hearing Suzanne Nielsen PhD MPS talk about this, and other policy interventions for prescription drug harm, at the RANZCP Congress in Canberra
congress.ranzcp.org

Suzi is our invited Faculty of Addiction speaker, speaking on Monday at 4pm, don’t miss it!

Are interventions aimed at reducing opioid prescribing in Australia reducing opioid harm? Some thoughts from Ting Xia and in the Medical Journal of Australia this week ... Monash Addiction Research Centre onlinelibrary.wiley.com/doi/epdf/10.56…

🚨📅 A reminder that applications for the @monashuni Research Fellow - Epidemiology role in the #NAMHSU team at Turning Point close on 25 March!

A great role, leveraging the unique National Ambulance Surveillance System ( #NASS ).

Monash Medicine, Nursing and Health Sciences EHCS Monash Monash Research

📢Would you like to be part of this group of diverse scientists?

We’re looking for PhD students with:

1. Background in ML, RL, active inference & neuroAI
2. Background in time series analysis, MRI brain connectivity methods
3. Background in psychedelics, MRI & EEG

Please RT

Loved this quote… “Regardless, five minutes of this podcast taught me more about the injecting room than all the coverage I’d consumed so far…I realised voices such as Adrian, Sammy and John are entirely missing from mainstream press coverage…”shows.acast.com/nobody-dies-he…

“In pursuit of safer supply: An emerging evidence base for medical and nonmedical models” by Suzanne Nielsen PhD MPS, MJ Stowe, & Alison Ritter (2024) via International Journal of Drug Policy…are healthcare providers supportive of safe supply in your region?

Link: sciencedirect.com/science/articl…

#SafeSupply

Definitely a good reason to keep #naloxone on hand. If you want to know more (as in, quite a bit more) about protonitazene - there are details on pharmacology and effects here in the World Health Organization (WHO) ECDD report (from page 57) ecddrepository.org/sites/default/…

🌟 First PhD Publication 🌟

We heard from people with lived and living experience that 911 calls were a source of tension due to instructions from emergency medical call takers for patients suffering drug poisoning emergencies, so we examined 1.6 mil cases to look into it.

We’re hiring! Come and join the great team at NAMHSU: careers.pageuppeople.com/513/cw/en/job/…

Turning Point Dan Lubman Victoria Manning EHCS Monash #pophealth #epi 🚑

New paper! 🚨Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis just published in the Lancet's eClinicalMedicine – The Lancet Discovery Science. Exciting for pharmacy to expand access to hep C testing/TM Burnet Institute Monash Addiction Research Centre authors.elsevier.com/sd/article/S25…

A limit of 24mg where the PI and safety data in Australia support up to 32mg per day has never made sense to me.

Shoes representing lives lost to #overdose in the #Melbourne CBD in the past 12 months. #KOCA (Keep Our City Alive) calling for immediate action on a 2nd drug consumption room in the CBD cohealth Family Drug Support Harm Reduction Vic VAADA Jacinta Allan Aiv Puglielli MP Rachel Payne MP